株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

蛋白尿:世界の治験動向

Proteinuria Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 326151
出版日 ページ情報 英文 92 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
蛋白尿:世界の治験動向 Proteinuria Global Clinical Trials Review, H2, 2015
出版日: 2015年09月10日 ページ情報: 英文 92 Pages
概要

当レポートでは、蛋白尿に関する臨床研究の最新動向について調査し、地域・進捗状況・フェーズ (相) ・募集状況別の実施件数や、代表的なスポンサー、開発中の治療薬の情報、世界各国の主要企業・機関での進行状況、有望な薬剤の比較といった情報を盛り込んでお届けします。

イントロダクション

  • 蛋白尿
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:泌尿生殖器系および性ホルモン関連の治験における蛋白尿の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:泌尿生殖器系および性ホルモン関連の治験における蛋白尿の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

蛋白尿治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Novartis AG
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Mallinckrodt plc
    • Actavis plc
    • AstraZeneca PLC
    • 第一三共
    • Cinkate Corporation
    • C. H. Boehringer Sohn AG & Co. KG
    • Abbott Laboratories
  • 代表的な研究機関・病院の治験の概要
    • Medical University of Gdansk
    • Tabriz University of Medical Sciences
    • U.S. Department of Veterans Affairs
    • Mayo Clinic
    • University Medical Center Groningen
    • Gulhane School of Medicine
    • Medical University of Vienna
    • Showa University
    • University of Alabama at Birmingham
    • Assistance Publique - Hopitaux de Paris

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2849CTIDB

GlobalData's clinical trial report, "Proteinuria Global Clinical Trials Review, H2, 2015" provides an overview of Proteinuria clinical trials scenario. This report provides top line data relating to the clinical trials on Proteinuria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Proteinuria
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Proteinuria
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Proteinuria Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Mallinckrodt Plc
      • Clinical Trial Overview of Mallinckrodt Plc
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Allergan Plc
      • Clinical Trial Overview of Allergan Plc
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Medical University of Gdansk
      • Clinical Trial Overview of Medical University of Gdansk
      • Gulhane School of Medicine
      • Clinical Trial Overview of Gulhane School of Medicine
      • Showa University
      • Clinical Trial Overview of Showa University
      • Tabriz University of Medical Sciences
      • Clinical Trial Overview of Tabriz University of Medical Sciences
      • University Medical Center Groningen
      • Clinical Trial Overview of University Medical Center Groningen
      • Chengdu University of Traditional Chinese Medicine
      • Clinical Trial Overview of Chengdu University of Traditional Chinese Medicine
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • The University of Hong Kong
      • Clinical Trial Overview of The University of Hong Kong
      • University of Alabama at Birmingham
      • Clinical Trial Overview of University of Alabama at Birmingham
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Proteinuria Therapeutics, Global, Clinical Trials by Region, 2015*
  • Proteinuria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Proteinuria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Proteinuria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Proteinuria Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Proteinuria Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Proteinuria Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proteinuria Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Proteinuria Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Proteinuria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Proteinuria Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Proteinuria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Proteinuria Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Proteinuria Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Proteinuria Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Proteinuria Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Proteinuria Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Proteinuria Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Proteinuria Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Proteinuria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Proteinuria Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Proteinuria Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Proteinuria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Proteinuria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Mallinckrodt Plc, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Gdansk, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Gulhane School of Medicine, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Showa University, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu University of Traditional Chinese Medicine, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2015*
  • Proteinuria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2015*

List of Figures

  • Proteinuria Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Proteinuria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Proteinuria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Proteinuria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Proteinuria Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Proteinuria Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proteinuria Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proteinuria Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Proteinuria Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Proteinuria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Proteinuria Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Proteinuria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Proteinuria Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Proteinuria Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Proteinuria Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Proteinuria Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Proteinuria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Proteinuria Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Proteinuria Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Proteinuria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Proteinuria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top